BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
FABP1
,
Fatty acid metabolic process
,
Diabetes mellitus
,
Stem cell
,
Biofuel
,
Aspirin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
dppe
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
Au14(2-SAdm)9(Dppe)2]+: a gold nanocluster with a crystallization-induced emission enhancement pheno…
Spontaneous N2-diboranylation of [W(N2)2(dppe)2] with B2Br4(SMe2)2.
Peptide transport in Bacillus subtilis - structure and specificity in the extracellular solute bindi…
High photoluminescence from self-assembled Ag2Cl2(dppe)2 clusters through metallophilic interactions…
On Heteronuclear Isoelectronic Alternatives to [Au13(dppe)5Cl2]3+: Electronic and Optical Properties…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
DPPE in Combination With Epirubicin and Cyclophosphamide in the Treatment of Breast Cancer
Tesmilifene in Combination With Docetaxel in the Treatment of Metastatic Breast Cancer
Pharmacokinetic Study of Tesmilifene (YMB1002) Plus Epirubicin and Cyclophosphamide in Metastatic Br…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ